EcoDrugPlus

Catechol-O-Methyltransferase

Ensembl ID : ENSBGRG00000021775
Gene Symbol: COMT
1 Cross references
277 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSBGRG00000025732
Gene Symbol: CTSC
1 Cross references
235 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSBGRG00000001240
Gene Symbol: CTSK
1 Cross references
246 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSBGRG00000002071
Gene Symbol: CDC7
1 Cross references
209 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSBGRG00000020448
Gene Symbol: CHEK1
1 Cross references
179 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSBGRG00000017522
Gene Symbol: CHEK2
1 Cross references
206 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSBGRG00000011346
Gene Symbol: CCKAR
1 Cross references
201 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSBGRG00000014135
Gene Symbol: CCKBR
1 Cross references
270 Possible Orthologues:

Cholinergic Receptor Muscarinic 2

Ensembl ID : ENSBGRG00000003358
Gene Symbol: CHRM2
1 Cross references
261 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSBGRG00000023830
Gene Symbol: CHRM3
1 Cross references
257 Possible Orthologues:

Cholinergic Receptor Muscarinic 4

Ensembl ID : ENSBGRG00000012936
Gene Symbol: CHRM4
1 Cross references
186 Possible Orthologues:

Cholinergic Receptor Nicotinic Alpha 3 Subunit

Ensembl ID : ENSBGRG00000019755
Gene Symbol: CHRNA3
1 Cross references
202 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).